Articles

Post-Marketing Reporting of Adverse Drug Reactions to Human Medicines in South Africa Recently Updated

Medicines Biologicals Herbal Cosmetic Nutra | South Africa

Every applicant is required to report ADRs known to them involving their marketed medicines in accordance with the requirements of Act 101 of 1965 Regulation 40. The success of the Authority’s ADR reporting system depends on the quality, completeness, and accuracy of the information submitted. Reporting of ADRs and monitoring thereof, remain a viable means of identifying previously unrecognized, rare, or serious ADRs.

This guideline describes the following points;

Pharmacovigilance Obligations of The Holder Of A Certificate Of Registration/ Applicant
Adverse Drug Reaction Reports
Procedures for Reporting

Read More Favorite

Lot Release Guideline for COVID – 19 Vaccines Recently Updated

Biologicals | South Africa

The lot release of human vaccines by the South African National Control Laboratory for Biological
Products are performed within the framework of the Medicines and Related Substances Act, 1965 (Act
No. 101 of 1965) as amended and Act 14 of 2015, regulations 15(1) and 15(2).

This guideline should be read together with the latest National Control Laboratory (NCL) circular on
General Information Regarding Vaccines and Lot Release, which is available on request at
(NclFHS@ufs.ac.za)

Read More Favorite

Pre- Registration Consultation Meeting Recently Updated

Biologicals | South Africa

This guidance document is to describe the procedures involved in the scheduling and conduct of Pre-Registration Consultation (PRC) meetings between the Office of the CRO of the SAHPRA and the applicant/sponsor of biological medicines. The primary purpose of the meetings is to address issues relating to the development of a product in the planning phase of such products.

This guideline describes the following points;

Terms, Definitions, and Abbreviations
Types of PRC Meetings
Procedure for Request To Schedule Meetings
Pre-Registration Consultation Meeting Material
Cancellation of Meeting

Read More Favorite

Post-Marketing Reporting of Adverse Drug Reactions to Human Medicines in South Africa Recently Updated

Lot Release Guideline for COVID – 19 Vaccines Recently Updated

Pre- Registration Consultation Meeting Recently Updated

Table Of Content of Tanzania

Table of Content of South Africa

Table of Content of Philippines

Table of Content of Indonesia

Table of Content of Thailand

Table of Content of Botswana

Table of Content of Vietnam